The Eli Lilly Lawsuit: What Nobody’s Saying About Compound GLP-1 Safety
The Eli Lilly lawsuit highlights significant safety concerns regarding compounded GLP-1 medications. Eli Lilly is targeting compound pharmacies for using untested additives in mixing tirzepatide. The publication discusses the substantial marketing of these compounds, often aimed at new patients, without adequate guidance on transitions from bulk purchases or management of side effects. Compounding, originally designed for specific patient needs, has morphed into a business model lacking proper oversight. As compounded medications become scarce, patients face difficult choices about their treatment. The importance of a supportive infrastructure and clear patient guidance is emphasized throughout this ongoing legal situation.
GLP-1, Weight Regain, and the WHO: What “Progressive and Relapsing” Actually Means
When the World Health Organization (WHO) released its GLP-1 guidelines, most people focused on access and prescribing. What went largely unnoticed was a shift in language that changes how obesity—and weight regain—are understood. This post breaks down what “chronic, progressive, and relapsing” actually means for women navigating long-term use of GLP-1 medications like Zepbound, Wegovy, Mounjaro, and Ozempic.
8 Things I Don’t Do As A GLP-1 Coach on Zepbound
Coach Insiya, a specialist in GLP-1 weight loss strategies, emphasizes a mindset shift for high-achieving women. She shares eight things she avoids, including setting goal weights, counting calories, and regularly weighing herself. Instead, she focuses on daily improvements, batch cooking, and monitoring general macros. Coach Insiya promotes openness about her journey while encouraging immediate action rather than postponing changes. She advises against letting self-criticism dictate one’s progress, emphasizing that success is defined by personal growth rather than numeric goals. Interested readers can access her GLP-1 Strategy Answer Guide for more insights and tips to enhance their weight loss strategy. Coach Insiya supports women on GLP-1 Medications such as Zepbound, Wegovy, Mounjaro and Ozempic.